Make your money go further for just 25p per day

AIM IHT

Coronavirus impact: 30 March - a hint of resilience

Bioventixantibody

The week has started with yet more dividend postponements and cancellations but also some fabulous results from one of the most resilient companies on the stock market.


Bioventix: reliability shines through

Bioventix (LON:BVXP), the developer of high-affinity monoclonal antibodies for applications in clinical diagnostics, has announced excellent interim results for the six months ending 31 December 2019. Revenue rose 21% to £5.3m and pre-tax profit was up 31% to £4.3m. The operating cash inflow was £4m with period end cash £5.5m - cashflows are crucial companies attempt to battle a the period of lockdown.

But Bioventix isn't facing as many challenges as other companies…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

Have your say

Log in or register to view or add comments.

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Alpha FX Group PLC

Why bother with an update!

12/01/2021 · Company Insights

There are a broad range of trading updates covered here, but we can’t understand why one company bothered, when…


Fabulous results from an ESG specialist

03/12/2020 · Company Insights

Results from this specialist investor, a pioneer in sustainable investment, highlight its considerable quality. From humble…


More on Bioventix PLC

Bonkers Bargain soars on takeover - more to go for?

29/03/2021 · Company Insights

Shares in an earlier Bonkers Bargain soar on a takeover approach, but there appears to be…


Coronavirus impact: 19 Oct - boohoo tumbles (again) but others impress

19/10/2020 · Company Insights

While boohoo’s travails continue to dominate the news on AIM, several other fast-growing companies covered here…


More on Flowtech Fluidpower Plc

A distinct lack of Swiss precision

26/01/2021 · Company Insights

Updates covered here include those from a highly-rated creator of textile treatments, which was unfortunately unable…


Coronavirus impact: 8 Sept - fabulous results from this AIM blue chip and much more

08/09/2020 · Company Insights

There were a large number of announcements today, including fabulous results from a fast growing provider of…


More on James Latham

Vaccine countdown update: 25 Nov - a day of frustrating adjustments

25/11/2020 · Company Insights

Listed company results are becoming increasingly hard to understand given the huge number of adjusting items.…


Illegal wages in unsafe working conditions: oh Boohoo!

06/07/2020 · Company Insights

The latest negative publicity for fast fashion group Boohoo calls into question its meteoric share price…


More Company Insights

Data specialist is thriving in a booming market

19/04/2021

Stonking Small Caps: this roller coaster is on the up

16/04/2021

Fast-growing consulting firm is looking good

12/04/2021 · Elixirr International